These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22273408)

  • 41. [Intravenous prostaglandin E2 in inductions of high risk labor].
    Iglesias E; de la Fuente P; González A; Olaizola JI; Alvarez Charines E; Garcia S Elvira JI
    Acta Obstet Ginecol Hisp Lusit; 1980 Apr; 28(4):261-80. PubMed ID: 7435172
    [No Abstract]   [Full Text] [Related]  

  • 42. Mistaken Identity Between the Maternal and Fetal Heart Rate: Ensuring Awareness of the Safety Features of the Electronic Fetal Heart Monitor.
    Hurko P; Ward TM; Corbett N
    Clin Nurse Spec; 2016; 30(1):7-10. PubMed ID: 26626740
    [No Abstract]   [Full Text] [Related]  

  • 43. A randomized clinical trial comparing vaginal misoprostol versus cervical Foley plus oral misoprostol for cervical ripening and labor induction.
    Hill JB; Thigpen BD; Bofill JA; Magann E; Moore LE; Martin JN
    Am J Perinatol; 2009 Jan; 26(1):33-8. PubMed ID: 18850516
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discontinuation of oxytocin in the active phase of labor.
    Girard B; Vardon D; Creveuil C; Herlicoviez M; Dreyfus M
    Acta Obstet Gynecol Scand; 2009; 88(2):172-7. PubMed ID: 19169930
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Labor stimulation by the intravenous administration of oxytocin in combination with prostaglandin F2 alpha (enzaprost)].
    Guliev ChK
    Akush Ginekol (Mosk); 1980 Jul; (7):29-31. PubMed ID: 7416366
    [No Abstract]   [Full Text] [Related]  

  • 46. Labor induction with the prostaglandin E1 methyl analogue misoprostol versus oxytocin: a randomized trial.
    Sanchez-Ramos L; Kaunitz AM; Del Valle GO; Delke I; Schroeder PA; Briones DK
    Obstet Gynecol; 1993 Mar; 81(3):332-6. PubMed ID: 8437780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The uses and limitations of the fetal biophysical profile.
    Oyelese Y; Vintzileos AM
    Clin Perinatol; 2011 Mar; 38(1):47-64, v-vi. PubMed ID: 21353089
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [New aspects of using oxytocin in obstetrical practice].
    Serov VN; Poliakov VV; Kozhin AA
    Akush Ginekol (Mosk); 1992; (3-7):3-6. PubMed ID: 1481960
    [No Abstract]   [Full Text] [Related]  

  • 49. Evolving concepts of oxytocin for induction of labor.
    Dawood MY
    Am J Perinatol; 1989 Apr; 6(2):167-72. PubMed ID: 2653335
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oxytocin-induced labor characteristics and uterine activity after preinduction cervical priming with prostaglandin E2 intracervical gel.
    Ferguson JE; Ueland FR; Stevenson DK; Ueland K
    Obstet Gynecol; 1988 Nov; 72(5):739-45. PubMed ID: 3173925
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fetal heart rate and cardiotocographic abnormalities with varying dose misoprostol vaginal inserts.
    Stephenson ML; Powers BL; Wing DA
    J Matern Fetal Neonatal Med; 2013 Jan; 26(2):127-31. PubMed ID: 22712609
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Failed induction of labor despite sequential prostaglandin E2 therapy.
    Karaiskakis PT; Rayburn WF; Smith CV; Woods RE
    Am J Perinatol; 1991 Mar; 8(2):128-30. PubMed ID: 2006938
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of oxytocin-induced uterine hyperstimulation during labor on fetal oxygen status and fetal heart rate patterns.
    Simpson KR; James DC
    Am J Obstet Gynecol; 2008 Jul; 199(1):34.e1-5. PubMed ID: 18342288
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oxytocin: new perspectives on an old drug.
    Clark SL; Simpson KR; Knox GE; Garite TJ
    Am J Obstet Gynecol; 2009 Jan; 200(1):35.e1-6. PubMed ID: 18667171
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nursing peer review of late deceleration recognition and intervention to improve patient safety.
    Davis J; Kenny TH; Doyle JL; McCarroll M; von Gruenigen VE
    J Obstet Gynecol Neonatal Nurs; 2013; 42(2):215-24. PubMed ID: 23488556
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Labor induction with continuous low-dose oxytocin infusion: a randomized trial.
    Mercer B; Pilgrim P; Sibai B
    Obstet Gynecol; 1991 May; 77(5):659-63. PubMed ID: 2014075
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Best practices in perinatal care: evidence-based management of oxytocin induction and augmentation of labor.
    Mahlmeister LR
    J Perinat Neonatal Nurs; 2008; 22(4):259-63. PubMed ID: 19011488
    [No Abstract]   [Full Text] [Related]  

  • 58. Oxytocin augmentation during labor: how to implement medical guidelines into clinical practice.
    Holmgren S; Silfver KG; Lind C; Nordström L
    Sex Reprod Healthc; 2011 Nov; 2(4):149-52. PubMed ID: 22055983
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinicians' guide to the use of oxytocin for labor induction and augmentation.
    Simpson KR
    J Midwifery Womens Health; 2011; 56(3):214-21. PubMed ID: 21535370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Labor progress indices and dynamics of the individual uterine contraction during the active stage of labor.
    Ophir E; Bornstein J; Odeh M; Kaminsky S; Shnaider O; Megel Y; Barnea O
    J Obstet Gynaecol Res; 2014 Mar; 40(3):686-93. PubMed ID: 24246065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.